Today's Top 20 StoriesRSS
A study published in Spine Deformity, the official journal of the Scoliosis Research Society, examines patients undergoing primary and revision vertebral column resection to compare correction rates and complications. 
Bacterin expanded its sales team, adding several people in key leadership roles.  
Shelton, Conn.-based Spine Wave hired Laine Mashburn as executive vice president of global marketing and business development. 
  Here are eight things for spinal surgeons to know for Oct. 16, 2014.  
A study recently published in Spine examined the cost effectiveness of using vancomycin in thoracolumbar adult deformity surgeries to curb infections. 
Globus Medical launched the SILC Fixation System for spinal deformity procedures. 
RBC Capital reported LDR's stock had the "outperform" rating reissued earlier this week, according to a Ticker Report. 
Johnson & Johnson's worldwide medical device and diagnostic sales hit $6.6 billion in the third quarter of 2014, a 5.2 percent decrease over the same period last year. 
Spine Wave released its lateral access product portfolio for full commercial launch.  
Amedica entered into a private labeling agreement with Spinal Kinetics. 
An article recently published in Spine examines spinal fusions for patients with pediatric idiopathic scoliosis in the United States for predictors of allogeneic blood transfusion. 
Mazor Robotics named SVP America & Global Marketing Christopher Prentice the CEO of Mazor Robotics, Inc., the subsidiary of Mazor Robotics Ltd. 
Bacterin reported preliminary third quarter financial results, including a total revenue increase over the same period last year. 
An article recently published in the Journal of Orthopaedic Trauma examines the trends and evolution of diagnostic imaging for trauma patients. 
The Food and Drug Administration cleared 20 spine-related devices in September. 
A study published in The Spine Journal examines where spine-related studies registered on www.ClinicalTrials.gov end up and publication rate for completed trials. 
A study published in Spine examines whether bone morphogenetic protein changes operative nonunion rates for spinal fusions. 
  MiMedx reported third quarter financial results, including increased revenue and its first quarterly profit.  
MedStar Georgetown University Hospital decided to craft a multi-faceted media campaign to target patients with back pain and spread the word about their minimally invasive spine surgery services. 
Bioventus, a provider of orthobiologic solutions, acquired the OsteoAMP product line from Advanced Biologics.  
Page 4 of 220